Ph.D. Gail K. Naughton - 07 Dec 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Director
Signature: /s/ Gail K. Naughton, Ph.D.
Issuer symbol: TXMD
Transactions as of: 07 Dec 2022
Net transactions value: -$20,635
Form type: 4
Filing time: 08 Dec 2022, 19:10:19 UTC
Previous filing: 03 Oct 2022
Next filing: 19 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Sale	$20,635	-3,922	-100%	$5.26	0	07 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.31, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.31, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.